Ledger.Open graph →
SEC Form D · filed May 12, 2014

Clearside Biomedical, Inc

Offering
$6.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Alpharetta, GA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Daniel H. White · Alpharetta, GAExec · DirectorGlenn D. Noronha · Alpharetta, GAExecWilliam C. Dunkelberg · Philadelphia, PADirectorChristy H. Shaffer · Durham, NCDirectorMark H. Prausnitz · Atlanta, GADirectorClay H. Thorp · Durham, NCDirectorCharles A. Deignan · Alpharetta, GAExecNate K. Redmond · SANTA MONICA, CADirectorStephen Socolof · San Jose, CADirectorJohn Stockton · San Jose, CADirectorShone M. Bagley, Sr · Brown Deer, WIExec · DirectorCharles F. Mcnairy · Kinston, NCDirectorJohn O. Mcnairy · Kinston, NCExecAlbert Hu · LOS ALTOS HILLS, CAExecJerry A. Cagle · Fort Worth, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗